|Articles|August 1, 2016
- Pharmaceutical Executive-08-01-2016
- Volume 36
- Issue 8
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Pharm Exec's 15th Annual Industry Auditover 9 years ago
The Industry Audit: Fifteen Years Rightover 9 years ago
Dealmaking in 2016: It’s Complicatedalmost 10 years ago
Steady Hands: AmerisourceBergen's Peyton Howellalmost 10 years ago
Drug Shortages Raise Economic and Ethical Challengesalmost 10 years ago
The ‘Cure’-All for 21st Century Data Sharingalmost 10 years ago
European Pharma and the Unified Patent Courtalmost 10 years ago
An EU Referendum ... on Drug Pricing?almost 10 years ago
Country Report: HungaryAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
What Pharma Investors Should Expect in the Current Regulatory Environment
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5